Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Samir Dourmane (Alger, Algeria), Samir Dourmane, Merzak Gharnaout. Epidemiological and clinical profile of lung cancer in Algiers. Eur Respir J 2015; 46: Suppl. 59, 4309

Member's Comments

No comment yet.

Related content which might interest you: Epidemiological changes of patients with lung cancer over Years Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Lung cancer in England: Trends in survival over the duration of the national lung cancer audit Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Predictors of lung cancer patients delay time in Serbia - a cross-sectional study Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Analysis of clinicopathological characteristics of 982 lung cancer patients and subsequent treatment – Epidemiology study Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Association between leptin and risk of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Relationship between risk factors for lung cancer and tumor size Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Symptom-to-treatment intervals in lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Clinical features and prognosis of multiple primary malignancies in patients with lung cancer Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 The effect of socioeconomic deprivation on non-small cell lung cancer survival in North East Essex Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Assessment of nutritional status in patients with primary lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Evaluation of incidental lung cancer in hospitalized patients with non-respiratory disease Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 General characteristics and therapeutic options in lung cancer in Turkey Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Does bronchial location of lung cancer influence overall survival? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Therapeutic management of non-small cell lung cancers in Tunisia Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Multiple primary malignancies in Japanese patients with non-small cell lung cancer Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Population’s understanding and degree of participation of a screening lung cancer programme Source: International Congress 2015 – Quality management in lung cancer Year: 2015